Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
BioLife Solutions
BLFS
$1.72B
| $14.6M | ﹤0.01% |
788,190
+31,022
| +4% | +$542K |
|
2102
Tompkins Financial
TMP
$1.45B
| $14.6M | ﹤0.01% |
290,252
+5,256
| +2% | +$267K |
|
2103
Cerence
CRNC
$389M
| $14.6M | ﹤0.01% |
926,363
+37,528
| +4% | +$635K |
|
|
NOVA
2104
DELISTED
Sunnova Energy
NOVA
| $14.5M | ﹤0.01% |
2,369,317
+77,895
| +3% | +$703K |
|
2105
RPC Inc
RES
$1.39B
| $14.5M | ﹤0.01% |
1,875,398
+31,334
| +2% | +$226K |
|
|
SBOW
2106
DELISTED
SilverBow Resources, Inc.
SBOW
| $14.5M | ﹤0.01% |
423,980
+36,540
| +9% | +$1.06M |
|
2107
Editas Medicine
EDIT
$432M
| $14.4M | ﹤0.01% |
1,944,763
+43,028
| +2% | +$358K |
|
|
CCRN
2108
DELISTED
Cross Country Healthcare
CCRN
| $14.4M | ﹤0.01% |
768,352
+14,349
| +2% | +$287K |
|
2109
Lennar Class B
LEN.B
$20.7B
| $14.4M | ﹤0.01% |
98,006
-1,383
| -1% | -$187K |
|
2110
Infosys
INFY
$50.3B
| $14.4M | ﹤0.01% |
801,424
+8,032
| +1% | +$156K |
|
|
PRA
2111
DELISTED
ProAssurance
PRA
| $14.3M | ﹤0.01% |
1,114,805
+7,259
| +0.7% | +$93.4K |
|
2112
Standard Motor Products
SMP
$870M
| $14.3M | ﹤0.01% |
427,203
+7,460
| +2% | +$273K |
|
2113
IDT Corp
IDT
$1.67B
| $14.3M | ﹤0.01% |
378,798
+6,167
| +2% | +$220K |
|
2114
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $14.3M | ﹤0.01% |
725,511
+25,898
| +4% | +$506K |
|
|
GOOD
2115
Gladstone Commercial Corp
GOOD
$641M
| $14.3M | ﹤0.01% |
1,031,953
+33,131
| +3% | +$431K |
|
2116
Xometry
XMTR
$5.42B
| $14.3M | ﹤0.01% |
845,308
+21,355
| +3% | +$579K |
|
|
SNCY
2117
DELISTED
Sun Country Airlines
SNCY
| $14.2M | ﹤0.01% |
942,721
+69,145
| +8% | +$996K |
|
2118
Mitek Systems
MITK
$853M
| $14.2M | ﹤0.01% |
1,007,314
+32,139
| +3% | +$394K |
|
2119
Argan
AGX
$7.84B
| $14.2M | ﹤0.01% |
280,927
+6,874
| +3% | +$322K |
|
|
ATXS
2120
DELISTED
Astria Therapeutics
ATXS
| $14.1M | ﹤0.01% |
1,001,744
+304,529
| +44% | +$3.79M |
|
2121
United States Lime & Minerals
USLM
$3.37B
| $14.1M | ﹤0.01% |
236,380
+6,760
| +3% | +$349K |
|
2122
FTAI Infrastructure
FIP
$551M
| $14.1M | ﹤0.01% |
2,238,724
+52,049
| +2% | +$241K |
|
2123
Bristow Group
VTOL
$1.38B
| $14M | ﹤0.01% |
515,089
+9,520
| +2% | +$254K |
|
2124
Accel Entertainment
ACEL
$1.01B
| $14M | ﹤0.01% |
1,186,810
+30,366
| +3% | +$324K |
|
2125
Fate Therapeutics
FATE
$294M
| $14M | ﹤0.01% |
1,905,983
+42,498
| +2% | +$263K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.